Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2
Ivermectin may block the attachment of the SARS-CoV-2 spike protein to the ACE2 receptor in the human cell membrane, as explained (https://iv.iiarjournals.org/content/34/5/3023) in the article “Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2,” published by in vivo, the journal of the International Institute of Anticancer Research.
That research is also supported by this study which similarly found that ivermectin can inhibit the entry of SARS-CoV-2 to the ACE2 receptor. Source (https://covid19up.org/3-ways-ivermectin-covid-19/) and Study https://iv.iiarjournals.org/content/34/5/3023
_______________________________
If you like our work please consider to donate :